Clinical study of Shenmai Injection combined with enteral nutrition in the treatment of hyperlipidemic severe acute pancreatitis
WANG Jian′gang1 WANG Yubo2 KONG Na1
1.Department of Gastroenterology, the Third People′s Hospital of Yunnan, Yunnan Province, Kunming 650011, China;
2.Department of Clinical Nutrition, the Third People′s Hospital of Yunnan, Yunnan Province, Kunming 650011, China
Abstract:Objective To investigate the efficacy and safety of Shenmai Injection combined with enteral nutrition in the treatment of hyper lipidemic severe acute pancreatitis (HLSAP). Methods Ninety-three patients with HLSAP admitted to the Third People′s Hospital of Yunnan from January 2016 to June 2018 were selected. According to the random number table method, the patients were divided into observation group (47 cases) and control group (46 cases). The control group was treated with enteral nutrition, the observation group was treated with Shenmai Injection combined with enteral nutrition. Both groups were treated continuously for 14 days. The clinical effect of the two groups was compared. The acute physiology and chronic health evaluation Ⅱ (APACHEⅡ) and Balthazar CT score were evaluated and compared between the two groups before and after treatment. The levels of serum prealbumin (PAB), albumin (ALB), triacylglycerol (TG), C-reactive protein (CRP), immunoglobulin A (IgA), immunoglobulin M (IgM) and immunoglobulin G (IgG) were detected and compared between the two groups before and after treatment. The occurrence of adverse reactions during the treatment was recorded. Results The total clinical effective rate of the observation group was 97.87% (46/47), which was significantly higher than 78.26% (36/46) of the control group, the difference was statistically significant (χ2 = 8.573, P = 0.003). After treatment, APACHEⅡ and Balthazar CT scores of the two groups were significantly lower than those before treatment (P < 0.05), which of the observation group were lower than the control group (P < 0.05). After treatment, the serum levels of PAB, ALB, IgA, IgM and IgG in the two groups were significantly higher than those before treatment (P < 0.05), the serum levels of TG and CRP were significantly lower than those before treatment (P < 0.05), and the improvement of serum levels of PAB, ALB, TG, CRP, IgA, IgM and IgG in the observation group was significantly better than those in the control group (P < 0.05). No serious adverse reactions were found during the treatment in both groups. Conclusion Shenmai Injection combined with enteral nutrition in the treatment of HLSAP has significant clinical efficacy, which can significantly improve the nutritional status, reduce inflammatory reaction, enhance immune function, and has good security.
王建刚1 王玉波2 孔娜1. 参麦注射液联合肠内营养治疗高脂血症性重症急性胰腺炎的临床研究[J]. 中国医药导报, 2019, 16(29): 136-140.
WANG Jian′gang1 WANG Yubo2 KONG Na1. Clinical study of Shenmai Injection combined with enteral nutrition in the treatment of hyperlipidemic severe acute pancreatitis. 中国医药导报, 2019, 16(29): 136-140.